Statewide analysis of missed opportunities for human papillomavirus vaccination using vaccine registry data

被引:36
作者
Kepka, Deanna [1 ,2 ,4 ]
Spigarelli, Michael G.
Warner, Echo L. [1 ,2 ]
Yoneoka, Yukiko [3 ]
McConnell, Nancy [3 ]
Balch, Alfred H. [4 ]
机构
[1] Univ Utah, Coll Nursing, 10 S 2000 E, Salt Lake City, UT 84112 USA
[2] Huntsman Canc Inst, Canc Control & Populat Sci, 2000 Circle Hope,Room 4144, Salt Lake City, UT 84112 USA
[3] Utah Dept Hlth, Utah Statewide Immunizat Informat Syst, 288 N 1460 W, Salt Lake City, UT 84116 USA
[4] Univ Utah, Dept Pediat, Div Clin Pharmacol, 100 N Mario Capecchi Dr, Salt Lake City, UT 84132 USA
来源
PAPILLOMAVIRUS RESEARCH | 2016年 / 2卷
基金
美国国家卫生研究院;
关键词
HPV vaccine; Adolescent; Preventive medicine; Demographic factors; Registries;
D O I
10.1016/j.pvr.2016.06.002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Human papillomavirus (HPV) vaccine 3-dose completion rates among adolescent females in the US are low. Missed opportunities impede HPV vaccination coverage. Methods: A population-based secondary data analysis of de-identified vaccination and demographic data from the Utah Statewide Immunization Information System (USIIS) was conducted. Records were included from 25,866 females ages 11-26 years at any time during 2008-2012 who received at least one of the following adolescent vaccinations documented in the USIIS: Tdap (Tetanus, Diphtheria, Pertussis), meningococcal, and/or influenza. A missed opportunity for HPV vaccination was defined as a clinical encounter where the patient received at least one adolescent vaccination, but not a HPV vaccine. Results: Of 47,665 eligible visits, there were 20,911 missed opportunities (43.87%). Age group, race/ethnicity, and rurality were significantly associated with missed opportunity (p < 0.0001). In a multi variable mixed-effects logistic regression model that included ethnicity, location and age, as fixed effects and subject as a random effect, Hispanics were less likely to have a missed opportunity than whites OR 0.59 (95% CI: 0.52-0.66), small rural more likely to have a missed opportunity than urban youth OR 1.8 (95% CI: 1.5-2.2), and preteens more likely than teens OR 2.4 (95% CI: 2.2-2.7). Conclusion: Missed clinical opportunities are a significant barrier to HPV vaccination among female adolescents. Interventions targeted at providers who serve patient groups with the highest missed opportunities are needed to achieve adequate protection from HPV-associated illnesses. Impact: This is one of the first studies to utilize state immunization information system data to assess missed opportunities for HPV vaccination. (C) 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:128 / 132
页数:5
相关论文
共 50 条
  • [41] Human papillomavirus (HPV) and HPV vaccine knowledge, the intention to vaccinate, and HPV vaccination uptake among male college students
    Kasymova, Salima
    [J]. JOURNAL OF AMERICAN COLLEGE HEALTH, 2022, 70 (04) : 1079 - 1093
  • [42] A systematic review with meta-analysis of parental interventions for human papillomavirus vaccine uptake
    Mohamed, Rowida
    Kelly, Kimberly M.
    Nili, Mona
    Kelley, George A.
    [J]. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2022, 62 (04) : 1142 - 1153
  • [43] Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling analysis
    Simms, Kate T.
    Laprise, Jean-Francois
    Smith, Megan A.
    Lew, Jie-Bin
    Caruana, Michael
    Brisson, Marc
    Canfell, Karen
    [J]. LANCET PUBLIC HEALTH, 2016, 1 (02) : E66 - E75
  • [44] Human papillomavirus (HPV) vaccine introduction in Sikkim state: Best practices from the first statewide multiple-age cohort HPV vaccine introduction in India-2018-2019
    Ahmed, Danish
    VanderEnde, Kristin
    Harvey, Pauline
    Bhatnagar, Pankaj
    Kaur, Nitasha
    Roy, Subhendu
    Singh, Neelam
    Denzongpa, Phumzay
    Haldar, Pradeep
    Loharikar, Anagha
    [J]. VACCINE, 2022, 40 : A17 - A25
  • [45] Parent-son decision-making about human papillomavirus vaccination: a qualitative analysis
    Alexander, Andreia B.
    Stupiansky, Nathan W.
    Ott, Mary A.
    Herbenick, Debby
    Reece, Michael
    Zimet, Gregory D.
    [J]. BMC PEDIATRICS, 2012, 12
  • [46] Human papillomavirus vaccine effectiveness by number of doses: Systematic review of data from national immunization programs
    Markowitz, Lauri E.
    Drolet, Melanie
    Perez, Norma
    Jit, Mark
    Brisson, Marc
    [J]. VACCINE, 2018, 36 (32) : 4806 - 4815
  • [47] Human papillomavirus vaccination coverage among young women in the three sub-Saharan African countries using Demographic and Health Surveys data
    Wassie, Mulugeta
    Zegeye, Alebachew Ferede
    Mekonen, Enyew Getaneh
    Tekeba, Berhan
    Ali, Mohammed Seid
    Gonete, Almaz Tefera
    Kassie, Alemneh Tadesse
    Workneh, Belayneh Shetie
    Alemu, Tewodros Getaneh
    Tamir, Tadesse Tarik
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [48] Human Papillomavirus Vaccine Introduction in South Africa: Implementation Lessons From an Evaluation of the National School-Based Vaccination Campaign
    Delany-Moretlwe, Sinead
    Kelley, Karen F.
    James, Shamagonam
    Scorgie, Fiona
    Subedar, Hasina
    Dlamini, Nonhlanhla R.
    Pillay, Yogan
    Naidoo, Nicolette
    Chikandiwa, Admire
    Rees, Helen
    [J]. GLOBAL HEALTH-SCIENCE AND PRACTICE, 2018, 6 (03): : 425 - 438
  • [49] Safety of Human Papillomavirus 9-Valent Vaccine: A Meta-Analysis of Randomized Trials
    Ferreira Costa, Ana Paula
    Oliveira Cobucci, Ricardo Ney
    da Silva, Janine Medeiros
    da Costa Lima, Paulo Henrique
    Giraldo, Paulo Cesar
    Goncalves, Ana Katherine
    [J]. JOURNAL OF IMMUNOLOGY RESEARCH, 2017, 2017
  • [50] Still a "female problem": a framing analysis of the Human Papillomavirus (HPV) vaccine in Chinese online news
    Xiao, Xizhu
    Su, Yan
    [J]. CHINESE JOURNAL OF COMMUNICATION, 2020, 13 (03) : 275 - 292